CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
Capital Com Australia Pty Ltd Australia (受监管于 ASIC) Capital Com UK Limited 受监管于 Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (受监管于 CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (受监管于 NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (受监管于 FSA) Capital Com Online Investments Ltd (受监管于 SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
您也可以联系我们： 致电 +44 2030978888 support@capital.com

交易 Angion Biomedica Corp. - ANGN CFD

0.5303
8.53%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 0.0824
多头隔夜费

Long position overnight fee

Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
-0.024068%
空头隔夜费

Short position overnight fee

Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* 0.4887
开盘价* 0.5279
1 年变化* -72.36%
日范围* 0.5242 - 0.5372
52 周范围 0.46-2.41
平均交易量（10 天） 28.11K
平均交易量（3 个月) 1.42M
市值 14.76M
市盈率 -100.00K
流通股 30.11M
收入 2.30M
EPS -1.29
股息（收益率 %） N/A
贝塔 -100.00K
下一个财报发布日期 Mar 28, 2023

所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low
Mar 22, 2023 0.4887 0.0096 2.00% 0.4791 0.4890 0.4791
Mar 21, 2023 0.4789 0.0248 5.46% 0.4541 0.4791 0.4493
Mar 20, 2023 0.4881 0.0001 0.02% 0.4880 0.4986 0.4739
Mar 17, 2023 0.4887 -0.0490 -9.11% 0.5377 0.5378 0.4823
Mar 16, 2023 0.5081 0.0198 4.05% 0.4883 0.5695 0.4883
Mar 15, 2023 0.4930 -0.0542 -9.90% 0.5472 0.5671 0.4888
Mar 14, 2023 0.5372 -0.0196 -3.52% 0.5568 0.5963 0.5372
Mar 13, 2023 0.5377 -0.0240 -4.27% 0.5617 0.5621 0.5208
Mar 10, 2023 0.5132 -0.0641 -11.10% 0.5773 0.5778 0.5054
Mar 9, 2023 0.5568 -0.0604 -9.79% 0.6172 0.6256 0.5375
Mar 8, 2023 0.5960 0.0078 1.33% 0.5882 0.6158 0.5882
Mar 7, 2023 0.6060 -0.0094 -1.53% 0.6154 0.6155 0.6056
Mar 6, 2023 0.6256 -0.0208 -3.22% 0.6464 0.6466 0.6079
Mar 3, 2023 0.6156 0.0290 4.94% 0.5866 0.6258 0.5865
Mar 2, 2023 0.5969 0.0009 0.15% 0.5960 0.6130 0.5960
Mar 1, 2023 0.5883 -0.0370 -5.92% 0.6253 0.6256 0.5855
Feb 28, 2023 0.6258 0.0006 0.10% 0.6252 0.6452 0.6252
Feb 27, 2023 0.6453 0.0001 0.02% 0.6452 0.6454 0.6451
Feb 24, 2023 0.6455 0.0006 0.09% 0.6449 0.6736 0.6264
Feb 23, 2023 0.6449 -0.0001 -0.02% 0.6450 0.6454 0.6367

Angion Biomedica Corp. Events

時間（協調世界時） (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2021 2020 2019 2018
总收入 28.312 2.88 1.487 4.029
收入 28.312 2.88 1.487 4.029
收入成本，共计 0.433 1.19 0.64 0.378
毛利 27.879 1.69 0.847 3.651
总营业费用 66.714 58.153 40.078 18.371
销售/一般/行政费用，总计 18.488 17.986 9.601 5.391
研究与开发 48.698 38.977 29.837 12.602
营业收入 -38.402 -55.273 -38.591 -14.342
利息收入（费用），非经营净值 -2.191 -8.249 0.488 0.401
其他，净值 -13.98 -16.527 -2.555 -6.084
税前净收入 -54.573 -80.107 -40.658 -20.025
税后净收入 -54.573 -80.107 -40.658 -20.025
未计算非常项目前的净收益 -54.573 -80.107 -40.658 -20.025
净收入 -54.573 -80.107 -40.658 -20.025
Total Adjustments to Net Income 0 -4.98
普通股股东可获收益 (不含非经常性项目) -54.573 -80.107 -40.658 -25.005
普通股股东可获收益 (含非經常性項目) -54.573 -80.107 -40.658 -25.005
摊薄净收入 -54.573 -80.107 -40.658 -25.005
摊薄后加权平均股 28.2448 14.7621 9.97635 9.97635
扣除特别项目的每股摊薄盈利 -1.93214 -5.42652 -4.07544 -2.50643
Dividends per Share - Common Stock Primary Issue 0 0
每股正常摊薄盈利 -1.96418 -5.4226 -4.07544 -2.50643
Gain (Loss) on Sale of Assets 0 -0.058
异常费用（收入） -0.905
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
总收入 1.648 25.941 1.46 0.54 0.371
收入 1.648 25.941 1.46 0.54 0.371
收入成本，共计 0.433 0 0 0
毛利 25.508 1.46 0.54 0.371
总营业费用 16.133 11.307 17.218 17.879 20.31
销售/一般/行政费用，总计 4.466 4.206 3.93 4.34 6.012
研究与开发 11.667 6.668 13.288 14.444 14.298
营业收入 -14.485 14.634 -15.758 -17.339 -19.939
利息收入（费用），非经营净值 0.206 -0.016 -0.074 0.067 -2.168
其他，净值 0.039 0.272 0.128 0.2 -14.58
税前净收入 -14.24 14.89 -15.704 -17.072 -36.687
税后净收入 -14.24 14.89 -15.704 -17.072 -36.687
未计算非常项目前的净收益 -14.24 14.89 -15.704 -17.072 -36.687
净收入 -14.24 14.89 -15.704 -17.072 -36.687
普通股股东可获收益 (不含非经常性项目) -14.24 14.89 -15.704 -17.072 -36.687
普通股股东可获收益 (含非經常性項目) -14.24 14.89 -15.704 -17.072 -36.687
摊薄净收入 -14.24 14.89 -15.704 -17.072 -36.687
摊薄后加权平均股 29.9592 29.9654 29.8296 29.6703 23.4438
扣除特别项目的每股摊薄盈利 -0.47531 0.49691 -0.52646 -0.57539 -1.56489
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -0.47531 0.49691 -0.52646 -0.60589 -1.56489
异常费用（收入） 0 0 -0.905
Gain (Loss) on Sale of Assets 0
  • 年度
  • 每季度
2021 2020 2019 2018
流动资产总额 91.247 42.297 6.106 25.679
现金和短期投资 88.756 34.607 5.571 25.512
现金等价物 88.756 34.607 5.571 25.512
应收账款总额，净额 0.806 5 0.44 0.107
Prepaid Expenses 1.031 0.352 0.095 0.06
Total Assets 96.513 47.347 11.886 26.628
Property/Plant/Equipment, Total - Net 4.437 4.228 4.781 0.017
Property/Plant/Equipment, Total - Gross 4.954 4.654 5.109 0.295
Accumulated Depreciation, Total -0.517 -0.426 -0.328 -0.278
Long Term Investments 0.723 0.822 0.999 0.932
Total Current Liabilities 11.296 107.449 26.575 7.355
Accounts Payable 4.71 5.578 11.239 0.534
Accrued Expenses 4.113 7.276 3.694 2.98
Notes Payable/Short Term Debt 0 51.43 5.848 0
Other Current Liabilities, Total 2.415 43.165 5.794 3.841
Total Liabilities 15.006 137.796 30.472 7.717
Total Long Term Debt 0.235 0.635 0 0
Other Liabilities, Total 3.475 29.712 3.897 0.362
Total Equity 81.507 -90.449 -18.586 18.911
Preferred Stock - Non Redeemable, Net 0 0 0
Common Stock 0.3 0.156 0.095 0.094
Additional Paid-In Capital 296.445 72.136 63.584 60.138
Retained Earnings (Accumulated Deficit) -215.135 -160.562 -80.455 -39.797
Treasury Stock - Common 0 -1.846 -1.81 -1.524
Total Liabilities & Shareholders’ Equity 96.513 47.347 11.886 26.628
Total Common Shares Outstanding 29.9591 15.3167 9.97635 9.97635
Other Current Assets, Total 0.654 2.338
Long Term Debt 0 0.635
Other Equity, Total -0.103 -0.333
Other Long Term Assets, Total 0.106
Current Port. of LT Debt/Capital Leases 0.058
Capital Lease Obligations 0.235
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 76.239 91.247 104.393 119.702 133.498
现金和短期投资 73.002 88.756 102.736 117.313 130.456
现金等价物 73.002 88.756 102.736 117.313 130.456
应收账款总额，净额 0 0.806 0 0 0
Prepaid Expenses 0.021 1.031 1.018 1.761 2.343
Other Current Assets, Total 3.216 0.654 0.639 0.628 0.699
Total Assets 81.258 96.513 109.94 125.359 139.2
Property/Plant/Equipment, Total - Net 4.209 4.437 4.652 4.776 4.787
Property/Plant/Equipment, Total - Gross 4.758 4.954 5.137 5.231 5.219
Accumulated Depreciation, Total -0.549 -0.517 -0.485 -0.455 -0.432
Long Term Investments 0.732 0.723 0.862 0.843 0.877
Other Long Term Assets, Total 0.078 0.106 0.033 0.038 0.038
Total Current Liabilities 10.381 11.296 17.946 20.524 16.963
Accounts Payable 3.433 4.71 7.679 9.307 6.69
Accrued Expenses 6.16 4.113 6.219 5.522 4.872
Notes Payable/Short Term Debt 0 0 0 0 0.895
Other Current Liabilities, Total 0.728 2.415 4.048 5.695 4.506
Total Liabilities 14.056 15.006 45.426 48.17 46.757
Total Long Term Debt 0.219 0.235 0 0 0
Long Term Debt 0 0 0 0
Other Liabilities, Total 3.456 3.475 27.48 27.646 29.794
Total Equity 67.202 81.507 64.514 77.189 92.443
Common Stock 0.3 0.3 0.304 0.303 0.3
Additional Paid-In Capital 296.476 296.445 298.518 295.636 292.67
Retained Earnings (Accumulated Deficit) -229.375 -215.135 -230.025 -214.321 -197.249
Treasury Stock - Common 0 -4.21 -4.21 -2.991
Other Equity, Total -0.199 -0.103 -0.073 -0.219 -0.287
Total Liabilities & Shareholders’ Equity 81.258 96.513 109.94 125.359 139.2
Total Common Shares Outstanding 29.9594 29.9591 29.9331 29.7976 29.6605
Current Port. of LT Debt/Capital Leases 0.06 0.058
Capital Lease Obligations 0.219 0.235
  • 年度
  • 每季度
2021 2020 2019 2018
净收入/起跑线 -54.573 -80.107 -40.658 -20.025
经营活动产生的现金 -52.643 -22.888 -24.589 -8.02
经营活动产生的现金 0.091 0.098 0.05 0.002
非现金物品 27.809 31.352 6.269 9.051
Cash Taxes Paid 0 0
已付现金利息 0.007 0 0
营运资金的变化 -25.97 25.769 9.75 2.952
投资活动产生的现金 -0.382 -0.041 -0.242 0
资本支出 -0.382 -0.041 -0.242 0
融资活动产生的现金 107.171 52.409 4.89 31.741
股票的发行（报废），净额 -0.617 20.813 -0.375 28.596
债务的发行（退还），净额 0.293 32.118 5.265 3.145
现金净变化 54.149 29.036 -19.941 23.721
融资现金流项目 107.495 -0.522
外汇效应 0.003 -0.444
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -14.24 -54.573 -69.463 -53.759 -36.687
Cash From Operating Activities -15.653 -52.643 -38.281 -23.082 -12.551
Cash From Operating Activities 0.032 0.091 0.059 0.029 0.006
Non-Cash Items 0.179 27.809 25.729 23.505 21.675
Changes in Working Capital -1.624 -25.97 5.394 7.143 2.455
Cash From Investing Activities 0 -0.382 -0.346 -0.285 -0.041
Capital Expenditures 0 -0.382 -0.346 -0.285 -0.041
Cash From Financing Activities -0.014 107.171 106.767 106.068 108.444
Financing Cash Flow Items 0 107.495 -5.52 -5.428 -2.797
Issuance (Retirement) of Stock, Net 0 -0.617 112.287 111.496 111.241
Issuance (Retirement) of Debt, Net -0.014 0.293 0 0 0
Foreign Exchange Effects -0.087 0.003 -0.011 0.005 -0.003
Net Change in Cash -15.754 54.149 68.129 82.706 95.849
Cash Interest Paid 0.007
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Satterfield (Thomas A Jr) Individual Investor 7.2983 2197825 623278 2022-12-31 LOW
Vifor (International), Ltd Corporation 6.6269 1995643 0 2023-03-15 LOW
EISA-ABC LLC Corporation 5.719 1722237 0 2023-03-15 LOW
Goldberg (Itzhak D) Individual Investor 5.6193 1692199 4213 2023-03-15 LOW
Venkatesan (Jay R) Individual Investor 3.9765 1197498 0 2023-03-15 LOW
BVF Partners L.P. Hedge Fund 3.5574 1071297 0 2022-12-31 LOW
Nantahala Capital Management, LLC Hedge Fund 3.4308 1033145 -32867 2022-12-31 MED
Ganzi (Victor F.) Individual Investor 3.25 978698 0 2023-03-15 LOW
CM Management, LLC Investment Advisor 2.4313 732178 132178 2022-12-31 MED
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.1386 644035 675 2022-12-31 LOW
Park West Asset Management LLC Hedge Fund 1.2311 370724 0 2022-12-31 MED
Bridgeway Capital Management, LLC Investment Advisor 0.5811 175000 0 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5593 168436 -451 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 0.4041 121700 -87277 2022-12-31 HIGH
Omenn (Gilbert S) Individual Investor 0.2667 80326 0 2023-03-15 LOW
Millennium Management LLC Hedge Fund 0.2502 75342 -50261 2022-12-31 HIGH
Raymond James & Associates, Inc. Research Firm 0.1992 60000 0 2022-12-31 LOW
Birchview Capital, LP Investment Advisor 0.1806 54392 0 2022-12-31 LOW
Ergoteles Capital Hedge Fund 0.1757 52913 -25944 2022-12-31 HIGH
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.1696 51069 1188 2022-12-31 LOW

为什么选择 Capital.com？让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
開倉

平倉

做空 做多
過去的表現並不是未來結果的可靠指標
盈利/失利

Angion Biomedica Corp. Company profile

关于 Angion Biomedica Corp.

Angion Biomedica公司是一家处于后期阶段的生物制药公司。 公司专注于小分子疗法的发现、开发和商业化，以解决急性器官损伤和纤维化疾病。 该公司的主要候选产品是ANG-3777。 其管线包括ANG-3070、rho激酶2（ROCK2）和CYP11B2。 其ANG-3777是一种肝细胞生长因子（HGF）模拟物，它正在评估多种急性器官损伤和相关适应症，包括急性肾损伤（AKI）和其他器官的损伤，如肺、中枢神经系统（CNS）和心脏。 公司还在评估ANG-3777在急性肺损伤（ALI）方面的适应症，重点是急性呼吸窘迫综合症（ARDS），以及急性中枢神经系统损伤。 公司的其他项目是治疗纤维化疾病，ANG-3070是一种酪氨酸激酶抑制剂（TKI），以及rho激酶2（ROCK2）的抑制剂。

Industry: Biotechnology & Medical Research (NEC)

7-57 Wells Avenue
NEWTON
MASSACHUSETTS 02459
US

收入报表

  • Annual
  • Quarterly

人们也观看

Gold

1,981.86 Price
+0.670% 1D Chg, %
多头隔夜费 -0.0086%
空头隔夜费 0.0004%
隔夜费时间 21:00 (UTC)
价差 0.30

Oil - Crude

71.43 Price
+1.730% 1D Chg, %
多头隔夜费 -0.0170%
空头隔夜费 -0.0050%
隔夜费时间 21:00 (UTC)
价差 0.03

US100

12,788.90 Price
+1.550% 1D Chg, %
多头隔夜费 -0.0241%
空头隔夜费 0.0018%
隔夜费时间 21:00 (UTC)
价差 1.9

XRP/USD

0.44 Price
+3.420% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00445

还在找一位您可以信任的经纪商吗？

加入成为全球500,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易